TAVEXIA LIFECARE LIMITED

Consumer Services · Retailing

BSE: 539519
₹1.16
▼ -0.02 (-1.69%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
69/100
Moderate
Valuation
50/100
Fairly Valued
Momentum
41/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹44 Cr
PE (TTM)
38.7
Industry median 38.7 (39 companies)
Price to Book
1.0
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-30.3
Free Cash Flow
₹-18 Cr
as of March 31, 2026
Industry median ₹1 Cr (69 companies)
EPS Growth (YoY)
-133.33%
as of June 30, 2026
Industry median 7.14% (47 companies)
Net Profit Growth (TTM)
5.30%
as of June 30, 2026
Industry median 19.53% (42 companies)
Operating Revenue Growth (TTM)
-17.57%
as of June 30, 2026
Industry median 10.76% (43 companies)
Profit Growth (YoY)
-2.27%
as of Sept. 30, 2025
Industry median 8.70% (47 companies)
Revenue Growth (YoY)
-80.76%
as of June 30, 2026
Industry median 13.18% (45 companies)
Current Ratio
1.39
as of March 31, 2026
Industry median 2.01 (67 companies)
Debt to Equity
0.08
as of March 31, 2026
Industry median 0.04 (54 companies)
Interest Coverage
5.65
as of June 30, 2026
Industry median 5.12 (51 companies)
Net Margin
30.82%
as of Sept. 30, 2025
Industry median 6.65% (48 companies)
Operating Margin (EBIT)
-138.42%
as of June 30, 2026
Industry median 8.41% (50 companies)
Operating Margin (TTM)
12.09%
as of June 30, 2026
Industry median 7.79% (51 companies)
Return on Assets
5.13%
as of March 31, 2026
Industry median 4.36% (49 companies)
Return on Capital Employed
3.95%
as of March 31, 2026
Industry median 11.79% (48 companies)
Return on Equity
5.59%
as of March 31, 2026
Industry median 9.52% (48 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.08)
  • No Return on equity is 15% or more (5.6%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.7%
Low 1.1600 · High 1.2000
1W return
-2.5%
Low 1.1400 · High 1.2000
1M return
14.9%
Low 0.9900 · High 1.2400
52W return
-43.4%
Low 0.7400 · High 1.2400
Lifetime High ₹50.7500 (Oct. 13, 2021)
Lifetime Low ₹0.7400 (Aug. 7, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
1.2
10D
1.2
20D
1.3
50D
3.3
100D
6.5
200D
10.9

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
97.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1.17
Pivot
First resistance1.19
Second resistance1.21
Third resistance1.23
First support1.15
Second support1.13
Third support1.11
Day RSI23.4
Day MFI69.9
Day MACD-0.37
Day MACD signal-0.55

Beta

1M-0.40
3M0.52
1Y0.52
3Y0.70

Price change analysis

↑ 14.9%
Over 1 Month
LowHigh
0.991.24
↓ -43.4%
Over 3 Months
LowHigh
0.741.24
↓ -43.4%
Over 6 Months
LowHigh
0.741.24
↓ -43.4%
Over 1 Year
LowHigh
0.741.24
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 38.7 (own history: 5.9–68.3)
Fair Value Zone
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹-0.0100

Ranks #45 of 52 in Retailing by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2024
  • Promoter3.11%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 4.01% to 3.11% in Mar 2024 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
6 May 2026 RG TRADERS Bulk Buy 2,111,809 0.7000 BSE
6 May 2026 JEMISHKUMAR ODHAVJIBHAI GABANI Bulk Sell 4,019,000 0.7000 BSE
30 Apr 2026 KUBER EQUITY SERVICES LLP Bulk Sell 2,175,000 0.7000 BSE
30 Apr 2026 RG TRADERS Bulk Buy 2,705,635 0.7000 BSE
30 Apr 2026 KANABAR PARAG SURESH Bulk Sell 2,732,023 0.7000 BSE
24 Apr 2026 KANABAR PARAG SURESH Bulk Sell 3,800,000 0.7000 BSE
22 Apr 2026 PRATEEK RAJESH GUPTA Bulk Sell 1,999,980 0.7000 BSE
21 Apr 2026 RG TRADERS Bulk Buy 3,416,838 0.7100 BSE
21 Apr 2026 AARSHI MANISH MEHTA Bulk Sell 3,592,877 0.7100 BSE
21 Apr 2026 KRISHNA KUMAR GOYAL Bulk Buy 5,000,000 0.7100 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Mayukh Dealtrade Limited to SATTVA SUKUN LIFECARE LIMITED

All corporate actions →

Corporate Announcements

All 18 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Tavexia Lifecare Ltd - 539519 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Tavexia Lifecare Ltd - 539519 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
29 Sep 2026 Board Meeting Tavexia Lifecare Ltd - 539519 - Board Meeting Intimation for Intimation Of Board Meeting
25 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
19 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
16 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
16 Sep 2026 Insider Trading / SAST Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
12 Sep 2026 Company Update Tavexia Lifecare Ltd - 539519 - Announcement under Regulation 30 (LODR)-Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (30.8%)
  • Low financial leverage (Debt/Equity 0.08)

Weaknesses

  • Low Return on Equity (5.6%)
  • Declining revenue YoY (-80.8%)
  • Declining profit YoY (-2.3%)

Opportunities

  • RSI in oversold territory (23.4) -- a technical rebound zone

Threats

  • PE above 35 (38.7) -- priced for continued strong execution
  • Down 43.4% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about TAVEXIA LIFECARE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.